Columbia Care Inc.

The company's financials show resilient growth, with revenue advancing from $126.19M in Q4 2022 to $129.18M in Q3 2023. Gross profit remained healthy with margins at 29% in Q3 2023 compared to 33% in Q4 2022. Operating income hit -$19.33M last quarter, sustaining a consistent -15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$1.58M. Net income dropped to -$36.73M, while earnings per share reached -$0.09. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.